Measurement of deubiquitinating enzyme activity via a suicidal HA-Ub-VS probe

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Deubiquitinating enzymes (DUBs) are a novel "drug-able" target for cervical cancer, and small-molecule inhibitors of DUBs are currently being evaluated as novel chemotherapeutic agents. In this chapter, we describe an enzyme activity assay to assess the selectivity of a putative small-molecule DUB inhibitor toward a subset of DUBs in cancer cell lines.

Original languageEnglish (US)
Title of host publicationCervical Cancer
Subtitle of host publicationMethods and Protocols
PublisherSpringer New York
Pages193-200
Number of pages8
ISBN (Electronic)9781493920136
ISBN (Print)9781493920129
DOIs
StatePublished - Oct 27 2014

Fingerprint

Enzyme Assays
Uterine Cervical Neoplasms
Cell Line
Pharmaceutical Preparations
Neoplasms
Deubiquitinating Enzymes

Keywords

  • Cervical cancer
  • Cysteine proteases
  • Deubiquitinating enzymes
  • Dub
  • Ha-ub-vs probe
  • Metalloproteases
  • P53
  • Protease inhibitors
  • Proteases
  • Proteasome
  • Ubiquitin

Cite this

Measurement of deubiquitinating enzyme activity via a suicidal HA-Ub-VS probe. / Rivard, Colleen; Bazzaro, Martina.

Cervical Cancer: Methods and Protocols. Springer New York, 2014. p. 193-200.

Research output: Chapter in Book/Report/Conference proceedingChapter

Rivard, Colleen ; Bazzaro, Martina. / Measurement of deubiquitinating enzyme activity via a suicidal HA-Ub-VS probe. Cervical Cancer: Methods and Protocols. Springer New York, 2014. pp. 193-200
@inbook{41dfe0893abe40f4b2761a662061d156,
title = "Measurement of deubiquitinating enzyme activity via a suicidal HA-Ub-VS probe",
abstract = "Deubiquitinating enzymes (DUBs) are a novel {"}drug-able{"} target for cervical cancer, and small-molecule inhibitors of DUBs are currently being evaluated as novel chemotherapeutic agents. In this chapter, we describe an enzyme activity assay to assess the selectivity of a putative small-molecule DUB inhibitor toward a subset of DUBs in cancer cell lines.",
keywords = "Cervical cancer, Cysteine proteases, Deubiquitinating enzymes, Dub, Ha-ub-vs probe, Metalloproteases, P53, Protease inhibitors, Proteases, Proteasome, Ubiquitin",
author = "Colleen Rivard and Martina Bazzaro",
year = "2014",
month = "10",
day = "27",
doi = "10.1007/978-1-4939-2013-6_14",
language = "English (US)",
isbn = "9781493920129",
pages = "193--200",
booktitle = "Cervical Cancer",
publisher = "Springer New York",

}

TY - CHAP

T1 - Measurement of deubiquitinating enzyme activity via a suicidal HA-Ub-VS probe

AU - Rivard, Colleen

AU - Bazzaro, Martina

PY - 2014/10/27

Y1 - 2014/10/27

N2 - Deubiquitinating enzymes (DUBs) are a novel "drug-able" target for cervical cancer, and small-molecule inhibitors of DUBs are currently being evaluated as novel chemotherapeutic agents. In this chapter, we describe an enzyme activity assay to assess the selectivity of a putative small-molecule DUB inhibitor toward a subset of DUBs in cancer cell lines.

AB - Deubiquitinating enzymes (DUBs) are a novel "drug-able" target for cervical cancer, and small-molecule inhibitors of DUBs are currently being evaluated as novel chemotherapeutic agents. In this chapter, we describe an enzyme activity assay to assess the selectivity of a putative small-molecule DUB inhibitor toward a subset of DUBs in cancer cell lines.

KW - Cervical cancer

KW - Cysteine proteases

KW - Deubiquitinating enzymes

KW - Dub

KW - Ha-ub-vs probe

KW - Metalloproteases

KW - P53

KW - Protease inhibitors

KW - Proteases

KW - Proteasome

KW - Ubiquitin

UR - http://www.scopus.com/inward/record.url?scp=84958662477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958662477&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-2013-6_14

DO - 10.1007/978-1-4939-2013-6_14

M3 - Chapter

SN - 9781493920129

SP - 193

EP - 200

BT - Cervical Cancer

PB - Springer New York

ER -